Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation. REFINE-PFA

NCT07275151 is registered in ClinicalTrials.gov with CathVision ApS as lead sponsor.

NCT NCT07275151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07275151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation. REFINE-PFA
Lead sponsor
CathVision ApS
Phase
Observational
Overall status
Recruiting
Start date
July 22, 2026
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation